Literature DB >> 10849493

Clinical-pathological comparison of clinical prostate cancer between Japanese Americans in Hawaii and Japanese living in Japan.

T Fukagai1, M Shimada, H Yoshida, T Namiki, R G Carlile.   

Abstract

In an attempt to determine the role of environmental factors in the etiology of prostate cancer, we compared the clinical-pathological findings of prostate cancer among Japanese Americans in Hawaii and Japanese living in Japan. Our study showed that prostate cancer in Japanese living in Japan is more advanced than in Japanese Americans. The findings indicate that screening for prostate cancer in Japan is far behind that in the USA. The difference in level of cancer screening also precluded our attempt to analyse environmental factors contributing to prostate cancer progression in the two groups. The variation in method of clinical detection of prostate cancer between the USA and Japan is also likely to contribute to the apparent difference in the incidence of the disease.

Entities:  

Mesh:

Year:  2000        PMID: 10849493     DOI: 10.1046/j.1365-2605.2000.00009.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  4 in total

1.  The impact of a family history of prostate cancer on the prognosis and features of the disease in Korea: results from a cross-sectional longitudinal pilot study.

Authors:  Kwang Suk Lee; Kyo Chul Koo; Byung Ha Chung
Journal:  Int Urol Nephrol       Date:  2017-09-13       Impact factor: 2.370

2.  The burden of prostate cancer in Asian nations.

Authors:  Jennifer Cullen; Sally Elsamanoudi; Stephen A Brassell; Yongmei Chen; Monica Colombo; Amita Srivastava; David G McLeod
Journal:  J Carcinog       Date:  2012-03-19

3.  Survey of clinical and pathological characteristics and outcomes of patients with prostate cancer.

Authors:  M Alizadeh; S Alizadeh
Journal:  Glob J Health Sci       Date:  2014-09-18

4.  Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naïve prostate cancer: a subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, Phase 3 study.

Authors:  Satoshi Fukasawa; Hiroyoshi Suzuki; Kazushiro Kawaguchi; Hidehisa Noguchi; Kentaro Enjo; Namphuong Tran; Mary Todd; Karim Fizazi; Nobuaki Matsubara
Journal:  Jpn J Clin Oncol       Date:  2018-11-01       Impact factor: 3.019

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.